$0.550
-0.007 (-1.33%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Citius Pharmaceuticals Inc (CTXR) Moving Averages Convergence Divergence (MACD) indicator is 0.01, suggesting CTXR is Buy.
Citius Pharmaceuticals Inc (CTXR) 20-Day simple moving average is 0.49, while Citius Pharmaceuticals Inc (CTXR) share price is $—, making it Buy.
Citius Pharmaceuticals Inc (CTXR) 60-Day simple moving average is 0.55, while Citius Pharmaceuticals Inc (CTXR) share price is $—, making it Buy.
Technical Analysis for CTXR
AI Technical CTXRAs of 2026-11-07, the technical board for Citius Pharmaceuticals Inc (CTXR) reads buy: 6 indicators are flashing buy, 3 are indicating sell, and 4 are neutral. Price at $0.55 sits below the 5-day and 200-day moving averages and above the 10-day, 20-day and 60-day.
Momentum readings: RSI stands at 55.091, MACD stands at 0.0107 (Buy), Stochastic %K stands at 68.305, Stochastic %D stands at 74.674 and CCI stands at 90.897.
CTXR trades above the 60-day SMA (0.55) and below the 200-day SMA (0.65). Immediate resistance sits at Classic R1 0.66, then R2 0.78. Support sits at Classic S1 0.40, then S2 0.27.
Citius Pharmaceuticals Inc (CTXR) Support & Resistance Level
Citius Pharmaceuticals Inc (CTXR) Technical Indicators
2026-11-07
| Name | Value |
|---|---|
| RSI_14 | 55.091 |
| STOCHk_14_3_3 | 68.305 |
| STOCHd_14_3_3 | 74.674 |
| CCI_20 | 90.897 |
| AO_5_34 | 0.048 |
| MOM_10 | 0.142 |
| MACD_12_26_9 | 0.011 |
Citius Pharmaceuticals Inc (CTXR) Relative Strength Index (RSI_14) is 55.091, creating a Neutral signal.
Citius Pharmaceuticals Inc (CTXR) Stochastic %K is 68.305, creating a Neutral signal.
Citius Pharmaceuticals Inc (CTXR) Stochastic %D is 74.674, creating a Neutral signal.
Citius Pharmaceuticals Inc (CTXR) CCI_20 is 90.897, creating a Neutral signal.
Citius Pharmaceuticals Inc (CTXR) Awesome Oscillator (AO) is 0.048, creating a Buy signal.
Citius Pharmaceuticals Inc (CTXR) Momentum (MOM) is 0.142, creating a Buy signal.
Citius Pharmaceuticals Inc (CTXR) Moving Average Convergence Divergence (MACD) is 0.011, creating a Buy signal.
Citius Pharmaceuticals Inc (CTXR) Moving Average
2026-11-07
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 0.558 | Sell |
| MA_10 | 0.537 | Buy |
| MA_20 | 0.487 | Buy |
| MA_60 | 0.545 | Buy |
| MA_200 | 0.650 | Sell |
| MA_250 | 0.726 | Sell |
Citius Pharmaceuticals Inc (CTXR) 5-Day simple moving average is 0.558, while Citius Pharmaceuticals Inc (CTXR) share price is $, making it a Sell.
Citius Pharmaceuticals Inc (CTXR) 10-Day simple moving average is 0.537, while Citius Pharmaceuticals Inc (CTXR) share price is $, making it a Buy.
Citius Pharmaceuticals Inc (CTXR) 20-Day simple moving average is 0.487, while Citius Pharmaceuticals Inc (CTXR) share price is $, making it a Buy.
Citius Pharmaceuticals Inc (CTXR) 60-Day simple moving average is 0.545, while Citius Pharmaceuticals Inc (CTXR) share price is $, making it a Buy.
Citius Pharmaceuticals Inc (CTXR) 200-Day simple moving average is 0.650, while Citius Pharmaceuticals Inc (CTXR) share price is $, making it a Sell.
Citius Pharmaceuticals Inc (CTXR) 250-Day simple moving average is 0.726, while Citius Pharmaceuticals Inc (CTXR) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.